• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA SRL SORIN BIOMEDICA SMARXT BCD VANGUARD SURFACE MODIFIED BLOOD CARDIOPLEGIA SYSTEM; CARDIOPLEGIA HEAT EXCHANGER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA SRL SORIN BIOMEDICA SMARXT BCD VANGUARD SURFACE MODIFIED BLOOD CARDIOPLEGIA SYSTEM; CARDIOPLEGIA HEAT EXCHANGER Back to Search Results
Catalog Number 050229
Device Problem Air Leak (1008)
Patient Problem No Patient Involvement (2645)
Event Date 10/17/2016
Event Type  malfunction  
Manufacturer Narrative
There was no patient involvement.The bcd vangaurd (item 050229, lot number 1602260145) is a non-sterile device that was assembled into convenience pack catalog number 044003200 and sterilized before distribution and use in the usa.The complained lot of bcd vangaurds was assembled into multiple lots of convenience pack 044003200, so the lot number is unknown.Expiration date (mm/dd/yyyy) of convenience pack: as the lot is unknown, the expiration date could not be determined.Device identifier (di) number for the convenience pack: 00803622111938.Device manufacture date (mm/dd/yyyy) of the convenience pack: as the lot number is unknown, the manufacture date could not be determined.The sorin biomedica smarxt bcd vanguard was assembled into a convenience pack distributed in the usa.The non-sterile cardioplegia heat exchanger is also distributed in the usa (510(k)number: k021830).Sorin group (b)(4) manufactures the sorin biomedica smarxt bcd vanguard.The incident occurred in (b)(6).This medwatch report is being filed on behalf of sorin group (b)(4).The investigation is on going.A follow-up report will be sent when the investigation is complete.
 
Event Description
Sorin group (b)(4) received a report that air was pulled into the top cap of the vanguard blood cardioplegia system and the unit emptied when it was exposed to a mild negative pressure during priming.There was no patient involvement.
 
Manufacturer Narrative
(b)(4).Sorin group (b)(4) manufactures the bcd vanguard blood cardioplegia system.The incident occurred in (b)(4).As per exemption number (b)(4).Sorin group (b)(4) is submitting follow-up report for both sorin group (b)(4) (manufacturer) and (b)(4).The bcd vanguard heat exchanger was returned to sorin group (b)(4) for evaluation.Visual inspection of the device did not reveal any defects.Simulated use testing was not able to replicate the reported depriming issue.However, leak testing identified a fluid leak from the top cap of the device.Fluid infiltration in that zone should not be allowed due to a hydrophobic membrane which separates top chamber into two compartments.The leak could be caused by an issue in the membrane.A dhr review did not highlight any relevant information regarding the reported issue.During manufacturing, 100% of bcd vanguard units are tested twice for correct functionality of the top valve.The reported depriming issue is not always reproducible due to movement of the top valve.Sorin group (b)(4) cannot exclude that the depriming reported by the customer was initially caused by the leak across the hydrophobic membrane, which can displace the top valve from its correct position.Despite the low defect rate for this type of issue, sorin group (b)(4) initiated a capa to identify the root cause for depriming.The capa investigation concluded that this type of problem is likely related to a non-perfectly seated top valve.As the event date was prior to the capa closure, it is likely that the convenience pack was manufactured prior to implementation of corrective actions.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SORIN BIOMEDICA SMARXT BCD VANGUARD SURFACE MODIFIED BLOOD CARDIOPLEGIA SYSTEM
Type of Device
CARDIOPLEGIA HEAT EXCHANGER
Manufacturer (Section D)
SORIN GROUP ITALIA SRL
strada statale 12 nord, 86
miradola (modena)
Manufacturer (Section G)
SORIN GROUP ITALIA, SRL.
strada statale 12 nord, 86
mirandola (modena) 41037
IT   41037
Manufacturer Contact
joan ceasar
14401 w 65th way
arvada, CO 80004
2812287260
MDR Report Key6107548
MDR Text Key60098434
Report Number9680841-2016-00515
Device Sequence Number1
Product Code DTR
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/21/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received11/16/2016
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number050229
Device Lot Number1602260145
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/24/2017
Is the Reporter a Health Professional? Yes
Distributor Facility Aware Date01/27/2017
Date Manufacturer Received01/27/2017
Was Device Evaluated by Manufacturer? Yes
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-